Gabelli & Co Investment Advisers’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-219,513
Closed -$12.9M 300
2023
Q4
$12.9M Buy
+219,513
New +$12.9M 2.42% 12